Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/1291
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWengstrom, Yvonneen_UK
dc.date.accessioned2012-04-15T13:32:20Z-
dc.date.available2012-04-15T13:32:20Z-
dc.date.issued2006-12en_UK
dc.identifier.urihttp://hdl.handle.net/1893/1291-
dc.description.abstractDr Yvonne Wengstrom (Karolinska Institutet, Stockholm, Sweden) is President of the European Oncology Nursing Society (EONS). She coordinates Care Science Research at the Karolinska Institutet and mentors undergraduate and postgraduate research students in oncology nursing. She is a member of the GAEA (Gathering Information on Adjuvant Endocrine Therapy) Initiative steering committee and recently led a survey which asked more than 500 women in 9 European countries about their experience of receiving adjuvant endocrine therapy for recently diagnosed breast cancer.en_UK
dc.language.isoenen_UK
dc.publisherElsevieren_UK
dc.relationWengstrom Y (2006) Patients need to know. European Journal of Cancer, 42 (18), p. 3083. http://www.sciencedirect.com/science/journal/09598049; https://doi.org/10.1016/j.ejca.2006.11.001en_UK
dc.rightsThe publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author; you can only request a copy if you wish to use this work for your own research or private study.en_UK
dc.rights.urihttp://www.rioxx.net/licenses/under-embargo-all-rights-reserveden_UK
dc.subjectadjuvant endocrineen_UK
dc.subjectbreast canceren_UK
dc.subjectCancer Adjuvant treatmenten_UK
dc.subjectBreast Canceren_UK
dc.subjectHormone therapyen_UK
dc.subjectPatient participationen_UK
dc.titlePatients need to knowen_UK
dc.typeJournal Articleen_UK
dc.rights.embargodate2999-12-07en_UK
dc.rights.embargoreason[Wengstrom Patients need to know1.pdf] We would like to delay access to this to article and request that the 'Request from author' option be added to this paper. The publisher does not allow this work to be made publicly available in this Repository therefore there is an embargo on the full text of the work.en_UK
dc.identifier.doi10.1016/j.ejca.2006.11.001en_UK
dc.citation.jtitleEuropean Journal of Canceren_UK
dc.citation.issn0959-8049en_UK
dc.citation.volume42en_UK
dc.citation.issue18en_UK
dc.citation.spage3083en_UK
dc.citation.publicationstatusPublisheden_UK
dc.citation.peerreviewedRefereeden_UK
dc.type.statusVoR - Version of Recorden_UK
dc.identifier.urlhttp://www.sciencedirect.com/science/journal/09598049en_UK
dc.author.emailyvonne.wengstrom@stir.ac.uken_UK
dc.citation.date06/12/2006en_UK
dc.contributor.affiliationKarolinska Instituteten_UK
dc.identifier.wtid817368en_UK
dcterms.dateAccepted2006-12-06en_UK
dc.date.filedepositdate2009-06-04en_UK
rioxxterms.typeJournal Article/Reviewen_UK
rioxxterms.versionVoRen_UK
local.rioxx.authorWengstrom, Yvonne|en_UK
local.rioxx.projectInternal Project|University of Stirling|https://isni.org/isni/0000000122484331en_UK
local.rioxx.freetoreaddate2999-12-07en_UK
local.rioxx.licencehttp://www.rioxx.net/licenses/under-embargo-all-rights-reserved||en_UK
local.rioxx.filenameWengstrom Patients need to know1.pdfen_UK
local.rioxx.filecount1en_UK
local.rioxx.source0959-8049en_UK
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles

Files in This Item:
File Description SizeFormat 
Wengstrom Patients need to know1.pdfFulltext - Published Version76.16 kBAdobe PDFUnder Embargo until 2999-12-07    Request a copy


This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.